{"id":60,"date":"2014-07-06T17:06:21","date_gmt":"2014-07-06T14:06:21","guid":{"rendered":"http:\/\/localhost\/tecimer\/?page_id=60"},"modified":"2014-10-10T15:36:47","modified_gmt":"2014-10-10T12:36:47","slug":"curriculum-vitae","status":"publish","type":"page","link":"https:\/\/coskuntecimer.com\/t\/curriculum-vitae","title":{"rendered":"Curriculum Vitae"},"content":{"rendered":"
\"Prof.Dr.Coskun<\/a>

Prof.Dr.Coskun Tecimer<\/p><\/div>\n\n\n\n\n\n\n\n\n\n
Name<\/td>\nCo\u015fkun Tecimer<\/td>\n<\/tr>\n
Place of Birth<\/td>\nK\u0131r\u015fehir, Turkey<\/td>\n<\/tr>\n
Date of Birth<\/td>\nJune 24, 1957<\/td>\n<\/tr>\n
Present Address<\/td>\nGayrettepe Florence Nightingale Hospital, Gayrettepe \/ \u0130stanbul<\/td>\n<\/tr>\n
Tel<\/td>\n(212) 2882476 Ext: 4184<\/td>\n<\/tr>\n
Fax<\/td>\n(212) 288 29 69<\/td>\n<\/tr>\n
Current Position<\/td>\nProfessor and specialist in Internal Medicine and Hematology\/Medical Oncology in Gayrettepe Florence Nightingale Hospital and \u0130stanbul Science University, Faculty of Medicine, Turkey<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n<\/table>\n

PROFESSIONAL EXPERIENCE<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
INSTITUTION and LOCATION<\/td>\nPOSITION<\/td>\nPERIOD<\/td>\n <\/td>\n<\/tr>\n
K\u00fcre Health Station, Kastomonu, Turkey<\/td>\nGeneral Practitioner<\/td>\n August 1981- March 1982<\/td>\n <\/td>\n<\/tr>\n
Karam\u00fcrsel Military Hospital, Kocaeli, Turkey\t<\/td>\nMilitary physician
\nMilitary service<\/td>\n		April 1982-August 1983<\/td>\n <\/td>\n<\/tr>\n
Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Ankara, Turkey<\/td>\nResident in Medicine<\/td>\nSeptember 1983-November 1987<\/td>\n <\/td>\n<\/tr>\n
Ministry of Education, Health Center, Ankara, Turkey<\/td>\nSpecialist in Internal Medicine<\/td>\nFebruary 1988-June 1991<\/td>\n <\/td>\n<\/tr>\n
In\u00f6n\u00fc University, Faculty of Medicine, Department of Internal Medicine, Malatya, Turkey<\/td>\nAssistant Professor of Medicine<\/td>\nJune 1991-October 1993<\/td>\n <\/td>\n<\/tr>\n
In\u00f6n\u00fc University, Faculty of Medicine, Department of Internal Medicine, Malatya, Turkey<\/td>\nAssociate Professor of Medicine<\/td>\nOctober 1993-October 1994<\/td>\n <\/td>\n<\/tr>\n
Marmara University, Faculty of\tMedicine, Department of Internal Medicine, Division of Hematology \/ Immunology, \u0130stanbul, Turkey<\/td>\nFellow in Hematology \/ Immunology<\/td>\nOctober 1994-January 1996<\/td>\n <\/td>\n<\/tr>\n
University of Louisville, Faculty of Medicine, Department of Internal Medicine, Division of Hematology\/Medical Oncology, Louisville, Kentucky, USA<\/td>\nFellow in Hematology \/ Medical Oncology<\/td>\nJanuary 1996-January 1999<\/td>\n <\/td>\n<\/tr>\n
Gayrettepe Florence Nightingale Hospital, Medical Oncology \/ Hematology, \u0130stanbul, TURKEY <\/td>\nAssociate Professor in Medical Oncology \/ Hematology<\/td>\nMarch 1999-June 2000<\/td>\n <\/td>\n<\/tr>\n
Gayrettepe Florence Nightingale Hospital, Kadir Has University, Division of Internal Medicine, \u0130stanbul, TURKEY<\/td>\nProfessor in Hematology \/ Medical Oncology Division of Internal Medicine<\/td>\nJune 2000-July 2004<\/td>\n <\/td>\n<\/tr>\n
Gayrettepe Florence Nightingale Hospital, Medical Oncology \/ Hematology, \u0130stanbul, TURKEY <\/td>\nProfessor in Medical Oncology \/ Hematology<\/td>\nJuly 2004-August 2006<\/td>\n <\/td>\n<\/tr>\n
Gayrettepe Florence Nightingale Hospital, \u0130stanbul Science University, Medical Oncology Division, \u0130stanbul,TURKEY<\/td>\nProfessor in Medical Oncology, Chief <\/td>\nAugust 2006-August 2009<\/td>\n <\/td>\n<\/tr>\n
Gayrettepe Florence Nightingale Hospital, Medical Oncology \/ Hematology, \u0130stanbul, TURKEY <\/td>\nProfessor in Medical Oncology \/ Hematology<\/td>\nAugust 2009-Present<\/td>\n <\/td>\n<\/tr>\n
Gayrettepe Florence Nightingale Hospital, \u0130stanbul Science University, Medical Oncology Division, \u0130stanbul,TURKEY<\/td>\nProfessor in Medical Oncology \/ Hematology<\/td>\nAugust 2012-Present<\/td>\n <\/td>\n<\/tr>\n<\/table>\n

PUBLICATIONS<\/p>\n

1-Tecimer C, Oram Y, Tecimer T. Lupus vulgaris in a patient with pulmonary tuberculosis. Cutis 1994; 53:246-8.
\n2- Tecimer C, Yam LT. Surreptitious superwarfarin poisoning with brodifacoum. Southern Medical Journal 1997; 90:1053-5.
\n3-Tecimer C, Loy BA, Martin AW. Acute myeloblastic leukemia (M0) with an unusual chromosomal abnormality: Translocation (1;14) (p13;q32). Cancer Genetics and Cytogenetics 1999; 111:175-7.
\n4-Tecimer C, Doering D, Abdulhay G, Goldsmith J, Meyer JS, Wittliff JL. Clinical relevance of urokinase-type plasminogen activator, its receptor and inhibitor type 1 in ovarian cancer. International Journal of Gynecological Cancer 2000; 10:372-81.
\n5-Tecimer C, Doering D, Abdulhay G, Goldsmith J, Meyer JS, Wittliff JL. Clinical relevance of urokinase-type plasminogen activator, its receptor and inhibitor type 1 in endometrial cancer. Gynecologic Oncology 2001; 80:48-55.
\n6-Al\u00e7o G, \u0130\u011fdem \u015e, Din\u00e7er M, Tecimer C, \u015eent\u00fcrk R, Vural M, Okkan S. Gemcitabine induced radiation recall myositis: Report of two cases. International Journal of Hematology and Oncology 2009; 19: 249-253.
\n7-Akun E, Okutur K, Seber S, Korkmaz T, Ayd\u0131n K, Bozkurt M, Namal E, Hasbal B, Tecimer C, Demir G. Safety and tolerability of first-line bevacizumab in metastatic colorectal cancer. Journal of Balkan Union of Oncology 2012; 17: 669-76.
\n8-Pilanc\u0131 KN, Elb\u00fcken F, Ordu \u00c7, K\u00f6ksal G, Tekelio\u011flu MH, Okutur K, G\u00f6ksel S, K\u00f6ksal \u00dc, Ak\u00e7al T, Tecimer C. A case of sunitinib induced hyperammonemic encephalopathy and hypothyroidism in metastatic renal cell carcinoma. American Journal of Theapeutics (in press)<\/p>\n

PRESENTATIONS<\/p>\n

1-Oto A, Tecimer C, Oram E, U\u011furlu \u015e, Karamehmeto\u011flu A, Oram A. Disturbance in the autonomic control of the heart rate in patients with acute myocardial infarction. Mediterranean Association of Cardiology and Cardiac Surgery 1st Annual Meeting, Cavtat-Dubrovnic Yugoslavia, October 8-11, 1987. Abstracts, 199.
\n2-Alpdo\u011fan O, Budak-Alpdo\u011fan T, Tanr\u0131verdi S, Tecimer C, F\u0131ratl\u0131-Tu\u011flular T, Bay\u0131k M, Ako\u011flu T. The efficacy of mega-dose methylprednisolon treatment in patients with idiopathic thrombocytopenic purpura. The 13th Meeting of the International Society of Haematology (European and African Division), \u0130stanbul, September 3-8, 1995. Abstract Book, Abstract No: 697.
\n3-Tecimer C, Bhupalam L, Djulbegovic B. Is standard heparin superior to low molecular weight heparin in malignancy related deep vein thrombosis? The 39th Annual Meeting of the American Society of Hematology, San Diego, CA, December 5-9, 1997. Blood 1997; 90: 124b.
\n4-Wittliff JL, Smolenkov AS, Tecimer C, Schmitt GA, Tuckson WB, Galandiuk S. Expression of urokinase-type plasminogen activator (uPA), its receptor (uPAR) and its inhibitor (PAI-1) in Russian and American patients with colon carcinoma. The Meeting of the Clinical Ligand Assay Society, New York, NY, Spring 1998. J Clin Ligand Assay 1998; 21: 87.
\n5-Tecimer C, Doering DL, Meyer JS, Abdulhay G, Goldsmith LJ, Wittliff JL. Prognostic significance of uPA, uPAR and PAI-1 expression in the management of endometrial cancer. The 35th Annual Meeting of the American Society of Clinical Oncology, Atlanta, GA, May 15-18, 1999. Proceedings 1999; 18: 160a.
\n6-Dane F, Yumuk PF, Turhal NS, Ekenel M, Ba\u015faran G, \u0130yikesici MS, Tecimer C. FOLFOX 4 in metastatic colorectal cancer (MCRC) patients who progressed after infusional 5-FU\/irinotecan based combination regimens. The 40th Annual Meeting of the American Society of Clinical Oncology, New Orleans, LA, June 5-8, 2004. J Clin Onc, 2004; 22: 301S.
\n7-\u0130\u011fdem \u015e, Alt\u0131n M, Al\u00e7o G, Ercan T, Kara B, \u00dcnalan B, Tecimer C, K\u00f6ksal G, Turkan S, Okkan S. PET\/CT guided, dose painting IMRT for nasopharyngeal carcinoma. Proceedings of the American Society for Therapeutic Radiology and Oncology 50th Meeting, 21-25 September, 2008 Boston, MA. Radiation Oncology Biology, Physics 2008; 72: S424-5.
\n8-Okutur K, Turan C, Tecimer C, Demir G. Toxicity of bevacizumab (BV) in metastatic colorectal cancer (MCRC): Data from clinical practice. 7th Congress of B.U.O.N., 16-19 October, 2008, \u0130zmir, Turkey. Journal of B.U.O.N. 2008; 13 (Suppl 1): S31.
\n9-Okutur K, Demir G, Tecimer C, Erdem L, Turan C. Toxicity of bevacizumab in metastatic colorectal cancer: Data from clinical practice. Poster presentation. 18th International Postgraduate Course of the International Association of Surgeons and Gastroenterologists and Oncologists, October 2008. Hepatogastroenterology Current Medical and Surgical Trends 2008; 55 (Suppl 1): S165-6.
\n10-Okutur K, Ayd\u0131n K, Bozkurt M, Turan C, Demir N, Hasbal B, Erdem L, Tecimer C, Demir G. Toxicity of bevacizumab in metastatic colorectal cancer: Data from clinical practice. 1st Congress of the Mediterranean Multidisciplinary Oncology Forum, 10-13 September 2009, Athens. Abstract 28.
\n11-\u0130\u011fdem \u015e, Alt\u0131n M, Al\u00e7o G, Ercan T, \u00dcnalan B, Tecimer C, K\u00f6ksal G, G\u00fcrses K, Demir G, Okkan S. Whole field simultaneous integrated boost IMRT in nasopharyngeal cancer. I J Radiation Oncology Biology Physics 2010; 78: S478.
\n12-Ba\u015faran G, Sa\u011flam S, Tansan S, Demirel M, G\u00f6kmen E, Aktan S, G\u00f6ker E, Kaban KK, Saip P, Demir G, Bavbek SE, Mandel NM, Tecimer C, Turhal NS, Garipo\u011flu M. The impact of 21-gene recurrence score (RS) scores on treatment decisions. Retrospective evaluation in Turkish early-stage breast cance (BC) patients. The 47th Annual Meeting of the American Society of Clinical Oncology, Chicago, IL, June 3-7, 2011. J Clin Onc, 2011; 29: Abstract No:e11042.
\n13-Bozkurt M, Okutur K, Ayd\u0131n K, Namal E, \u00d6zt\u00fcrk A, Tecimer C, Ak\u00e7al\u0131 Z, Demir G. The impact of early thromboembolic event on prognosis in cancer patients: A single-center analysis of 1838 patients. The 47th Annual Meeting of the American Society of Clinical Oncology, Chicago, IL, June 3-7, 2011. J Clin Onc, 2011; 29: Abstract No:e19694.
\n14-Pilanc\u0131 KN, Ordu \u00c7, Okutur K, \u0130ner Koksal \u00dc, Sa\u011flam S, Tecimer C, Demir G. 17. European Cancer Congress, Amsterdam, 27 September-1 October 2013.
\n15-Al\u00e7o G, \u0130\u011fdem \u015e, Din\u00e7er M, \u00d6zmen V, Demir G, K\u00f6ksal G, Tecimer C, Selamo\u011flu D, Pilanc\u0131 KN, Okkan S. Can megestrol acetate induce thrombosis in oncology patients? 17. European Cancer Congress, Amsterdam, 27 September-1 October 2013.<\/p>\n

 
\n 
\n <\/p>\n","protected":false},"excerpt":{"rendered":"

Name Co\u015fkun Tecimer Place of Birth K\u0131r\u015fehir, Turkey Date of Birth June 24, 1957 Present Address Gayrettepe Florence Nightingale Hospital, Gayrettepe \/ \u0130stanbul Tel (212) 2882476 Ext: 4184 Fax (212) 288 29 69 Current Position Professor and specialist in Internal Medicine and Hematology\/Medical Oncology in Gayrettepe Florence Nightingale Hospital and \u2026<\/p>\n

Devam\u0131n\u0131 Oku<\/i><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"templates\/template-onecolumn.php","meta":[],"_links":{"self":[{"href":"https:\/\/coskuntecimer.com\/t\/wp-json\/wp\/v2\/pages\/60"}],"collection":[{"href":"https:\/\/coskuntecimer.com\/t\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/coskuntecimer.com\/t\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/coskuntecimer.com\/t\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/coskuntecimer.com\/t\/wp-json\/wp\/v2\/comments?post=60"}],"version-history":[{"count":11,"href":"https:\/\/coskuntecimer.com\/t\/wp-json\/wp\/v2\/pages\/60\/revisions"}],"predecessor-version":[{"id":717,"href":"https:\/\/coskuntecimer.com\/t\/wp-json\/wp\/v2\/pages\/60\/revisions\/717"}],"wp:attachment":[{"href":"https:\/\/coskuntecimer.com\/t\/wp-json\/wp\/v2\/media?parent=60"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}